Specifically, some studies showed that Ewing sarcoma cells are sensitive to PARP1 inhibition [64–65], and our high-throughput screening results also showed that the two Ewing cells are sensitive to a PARP1 inhibitor, BMN 673. The gene discussed is PARP1; the disease is Ewing sarcoma.